Novel Pyrrolopyridazine VEGFR Tyrosine Kinase Inhibitors for Treating Cancer

Provided herein are novel pyrrolopyridazine VEGFR tyrosine kinase inhibitors, pharmaceutical compositions, use of such compounds in treating cancer, and processes for preparing such compounds.

Authors

Publication Details

Journal
ACS Medicinal Chemistry Letters
Published
2026-03-03
DOI
https://doi.org/10.1021/acsmedchemlett.6c00108
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel Pyrrolopyridazine VEGFR Tyrosine Kinase Inhibitors for Treating Cancer

Ram W. Sabnis
ACS Medicinal Chemistry Letters
Chronic Lymphocytic Leukemia Research
article

Novel Pyrrolopyridazine VEGFR Tyrosine Kinase Inhibitors for Treating Cancer

Ram W. Sabnis
article en

Abstract

Provided herein are novel pyrrolopyridazine VEGFR tyrosine kinase inhibitors, pharmaceutical compositions, use of such compounds in treating cancer, and processes for preparing such compounds.

ACS Medicinal Chemistry LettersVol. 17(3)
Good health and well-being
Openalex Percentile: Top 37%
Chronic Lymphocytic Leukemia Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Novel Pyrrolopyridazine VEGFR Tyrosine Kinase Inhibitors for Treating Cancer — Ram W. Sabnis · ACS Medicinal Chemistry Letters (2026) | TGRS Research Map | TGRS